Kom igång
Pokethebear

AVEO missed earnings - kidney cancer treatment too thinly traded

Lång
Pokethebear Uppdaterad   
NASDAQ:AVEO   None
Fibonacci Supply and Demand Beyond Technical Analysis oncology kidney pharmaceuticals pharmastocks clinical fullretracement NEW LOW entrypoint
2
0
fibonacci supplyanddemand beyondta oncology kidney pharmaceuticals pharmastocks clinical fullretracement new low entrypoint
Medical stock that's too thinly traded got mixed review on clinical trial results on Tivozanib, which showed efficacy, just not to level expected and testing new low for 2018 at 2.03 and below full fibonacci retracement of 2.10 as prior low. NASDAQ:AVEO
Kommentera:
snapshot
Currently at 618fibretracement
Kommentera:
Full 241% retracement and bounce to 161%. Sign of bouncing cat?
Frånsägelse av ansvar

Informationen och publikationerna är inte avsedda att vara, och utgör inte heller finansiella, investerings-, handels- eller andra typer av råd eller rekommendationer som tillhandahålls eller stöds av TradingView. Läs mer i Användarvillkoren.